C
Caixia Wu
Researcher at Peking University
Publications - 5
Citations - 32
Caixia Wu is an academic researcher from Peking University. The author has contributed to research in topics: Internal medicine & Standardized uptake value. The author has an hindex of 2, co-authored 3 publications receiving 8 citations.
Papers
More filters
Journal ArticleDOI
2-[18F]FDG PET/CT parameters associated with WHO/ISUP grade in clear cell renal cell carcinoma.
Yanyan Zhao,Caixia Wu,Wei Li,Xueqi Chen,Ziao Li,Xuhe Liao,Yonggang Cui,Guangyu Zhao,Meng Liu,Zhanli Fu +9 more
TL;DR: Elevated TLR (> 1.63) and presence of tumor thrombus from preoperative 2-[ 18 F]FDG PET/CT can distinguish high WHO/ISUP grade ccRCC effectively and may be a feasible method for noninvasive assessment of World Health Organization/the International Society of Urological Pathology (WHO/ISup) grade.
Journal ArticleDOI
Prediction and evaluation of neoadjuvant chemotherapy using the dual mechanisms of 99mTc-MIBI scintigraphy in patients with osteosarcoma.
Caixia Wu,Qian Wang,Yuan Li +2 more
TL;DR: 99mTc-MIBI imaging is a useful tool for the evaluation of neoadjuvant chemotherapy in patients with osteosarcoma, and its dual mechanisms could be simultaneously used in predicting and evaluating tumor response to chemotherapy.
Journal ArticleDOI
Noninvasive evaluation of tumor immune microenvironment in patients with clear cell renal cell carcinoma using metabolic parameter from preoperative 2-[ 18 F]FDG PET/CT
Caixia Wu,Yonggang Cui,Jumei Liu,Linlin Ma,Yan Xiong,Yanqing Gong,Yanyan Zhao,Xi Zhang,Silu Chen,Qun He,Jianhua Zhang,Meng Liu,Yan Fan +12 more
TL;DR: Wang et al. as mentioned in this paper investigated whether the metabolic parameter from preoperative 2-[18F]FDG PET/CT could provide information related to tumor immune microenvironment (time) in patients with clear cell renal cell carcinoma (ccRCC).
Journal ArticleDOI
PET/CT molecular imaging in the era of immune-checkpoint inhibitors therapy
TL;DR: A comprehensive overview of the clinical data to support the importance of 18F-fluorodeoxyglucose PET/ CT (18F-FDG PET/CT) imaging in the treatment of ICIs, including the evaluation of the tumor microenvironment, discovery of immune-related adverse events, evaluation of therapeutic efficacy, and prediction of therapeutic prognosis is provided.
Journal ArticleDOI
Diagnostic performance and prognostic value of preoperative 18F-FDG PET/CT in renal cell carcinoma patients with venous tumor thrombus
Silu Chen,Yanyan Zhao,Qi Tang,Caixia Wu,Aixiang Wang,Lin Feng Ma,Xi Zhang,Jinzhi Chen,Yuan-Mei Gao,Xuhe Liao,Ninghan Feng,Yan Fan,Jinhua Zhang,Xue-rong Li,Meng Liu +14 more
TL;DR: In this article , the diagnostic efficacy of preoperative fluorine-18 fluorodeoxyglucose (18 F-FDG) positron emission tomography/computed tomography (PET/CT) upon venous tumor thrombus (VTT) in patients with renal cell carcinoma (RCC) was investigated.